IDH2 and central nervous system cancer: Since we detected loss of 5-hmC in a subset of chondrosarcomas, which was not correlated with IDH mutation status, we evaluated whether, similar to gliomas [26], loss of 5-hmC was associated with nuclear exclusion of TET1.